A major goal of post-genomic biology is to reconstruct and model in silico the metabolic networks of entire organisms. Work on bacteria is well advanced, and is now under way for plants and other eukaryotes. Genome-scale modelling in plants is much more challenging than in bacteria. The challenges come from features characteristic of higher organisms (subcellular compartmentation, tissue differentiation) and also from the particular severity in plants of a general problem: genome content whose functions remain undiscovered. This problem results in thousands of genes for which no function is known ('undiscovered genome content') and hundreds of enzymatic and transport functions for which no gene is yet identified. The severity of the undiscovered genome content problem in plants reflects their genome size and complexity. To bring the challenges of plant genome-scale modelling into focus, we first summarize the current status of plant genome-scale models. We then highlight the challenges -and ways to address them -in three areas: identifying genes for missing processes, modelling tissues as opposed to single cells, and finding metabolic functions encoded by undiscovered genome content. We also discuss the emerging view that a significant fraction of undiscovered genome content encodes functions that counter damage to metabolites inflicted by spontaneous chemical reactions or enzymatic mistakes.
Introduction
The completion of the first bacterial genome sequence (Haemophilus influenzae) in 1995 opened a tantalizing prospect: constructing a computational model of an organism that predicts its entire operation from genome sequence alone. This prospect led to the Arabidopsis 2010 project to build a 'virtual plant' (Somerville and Dangl, 2000) . Developing such a model of a whole organism requires detailed knowledge of the function of all its genes, of how those genes co-operate to drive the machinery of life and, for a multicellular organism, of how different tissues form and interact.
The past 15 years have seen much progress towards this goal, particularly in genome sequencing, annotation, and metabolic reconstruction (i.e. the systematic inventorying of the metabolic pathways specified by a genome). Complete genome sequences now exist for >1700 prokaryotes and several plants, with many more in progress (Benson et al., 2011) . This availability of thousands of genomes has enabled comparative genomics approaches to improve annotation accuracy, coverage, and efficiency (Overbeek et al., 2005) . High-throughput experimental approaches such as genome-wide mutagenesis coupled with phenomics are being used to associate genes with phenotypes and so reveal gene function (Nichols et al., 2011) . Finally, genomescale models of metabolism have been generated for >80 organisms (Feist et al., 2009) ; draft models are now available for hundreds more (Henry et al., 2010) .
Genome-scale metabolic models provide a means to explore an organism's metabolic capabilities and limitations based on the enzymes and transporters encoded by its genes.
Models consist of four basic elements: (i) a list of enzymecatalysed metabolic reactions; (ii) bounds on reaction fluxes that dictate the directionality, reversibility and, when possible, capacity of these reactions; (iii) gene-protein-reaction (GPR) associations that link reaction activity to gene activity; and (iv) one or more objective functions that describe what cellular activity is being 'optimized for' (e.g. maximizing efficiency of biomass synthesis).
Genome-scale metabolic modelling is well established for microbes, with detailed protocols and even automated pipelines available for the development of new models (Aziz et al., 2008; Henry et al., 2010; Thiele and Palsson, 2010) . Microbial models have become powerful tools to connect phenotype and genotype, with applications that include predicting gene essentiality and culture requirements, designing metabolic engineering strategies, interpreting 'omics data sets, and correcting gene annotations (Feist and Palsson, 2008) . By contrast, metabolic modelling of plants remains very limited; this reflects the many challenges involved, from gene-calling through to the compartmentation of reactions in organelles and in distinct cell types.
This review maps out the current frontiers of metabolic modelling in plants. First, we survey current metabolic reconstruction efforts for four plants and eight corresponding genome-scale models, most of which include organellar compartmentation of reactions. We next consider identifying and filling gaps in metabolic reconstructions and models, and modelling tissues rather than single cells. Lastly, we briefly discuss the problem of genes whose function is uncertain or unknown ('undiscovered genome content'), and how part of this functionally undiscovered content may be accounted for by under-recognized enzymes that counter damage to metabolites.
Overview of current genome-scale plant models

Annotation and metabolic reconstruction of plant genomes
Metabolic modelling begins with the annotation and subsequent reconstruction of the metabolism for the genome to be modelled . Arabidopsis thaliana was the first plant genome released (Arabidopsis Genome Initiative, 2000) and, as noted above, many others continue to follow. Due to the complexity of plant genomes and to the continuing influx of post-genomic data, defining what constitutes the active gene set is an ongoing process, for example, The Arabidopsis Information Resource (TAIR) has just released the tenth revision of the Arabidopsis genome. Plant models will thus, for the foreseeable future, continue to be built on somewhat shifting foundations (active gene sets).
The metabolic annotation of newly sequenced genomes is based largely on protein homology. For microbes, servers such as IMG (Markowitz et al., 2010) and RAST (Aziz et al., 2008) assign putative metabolic functions to predicted proteins in this way. In essence, these servers propagate by homology initial annotations made in a few model organisms by expert curators. Curators use literature resources to make functional assignments, group sets of reactions into pathways, and propose new functional assignments for previously unknown proteins.
Various species-specific and generic plant databases now exist that compile the list of reactions believed to take part in the metabolic pathways of plant species based on their gene annotations. Species-specific databases include AraCyc (Zhang et al., 2005) , MaizeCyc (Jaiswal, 2011; Youens-Clark et al., 2011), and KEGG-ath (Kanehisa et al., 2010) . Generic plant databases include PlantCyc (Caspi et al., 2010; Karp et al., 2010; Zhang et al., 2010) and KEGG (Kanehisa et al., 2010) . Comparisons of the various metabolic reconstructions for specific plants reveal significant overlap, but also surprising differences (Fig. 1) . The similarity of the monocot databases to AraCyc may be an artefact of the way they are generated. Heuristic algorithms are used to determine whether a species contains a pathway and all of the reactions in this pathway may then be copied into the species-specific database from a parent database like PlantCyc regardless of whether there is evidence for the presence of the reactions and genes involved . Plant species may thus end up with very similar sets of reactions by default. Curation can address this issue.
In order to leverage all available data, it is necessary to integrate information from various metabolic databases, especially KEGG and BioCyc. Care must be taken to identify the equivalent reactions and compounds in these databases to ensure that nothing is unwittingly duplicated-a non-trivial task. Recently, Radrich et al. (2010) sought to merge the reactions and compounds found in KEGG-ath and AraCyc. Out of a full set of 2328 compounds and 2315 reactions, they could only be sure that 914 compounds and 753 reactions had identical references in both databases.
Genome-scale metabolic models of plants
Metabolic reconstructions provide the reaction compilation, gene-protein-reaction associations, and estimates of reaction localization, directionality, and reversibility that form the core of a genome-scale metabolic model. Models expand upon the content of metabolic reconstructions by adding elements required to simulate the natural activity of the organism and to predict the impact of genetic or environmental perturbations. These new elements include: (i) one or more objective functions (see above); (ii) a biomass composition reaction defining the ratio of small molecules that must be produced in order to generate biomass; and (iii) other reactions needed to fill gaps in the model that prevent the simulation of model objective functions.
While smaller-scale metabolic models have been constructed for various plant species (Allen et al., 2009; Grafahrend-Belau et al., 2009; Pilalis et al., 2011) , genomescale models are, as yet, available only for Arabidopsis, maize (Zea mays), sorghum (Sorghum bicolor), and sugarcane (Saccharum officinarum). To date, four separate groups have published a genome-scale Arabidopsis model.
The first two models, a heterotrophic cell suspension model (Poolman et al., 2009) and AraGEM (Dal'Molin et al., 2010a), were followed by two from other groups, either published or made available for public use (Mintz-Oron et al., 2011; Saha et al., 2011) . In parallel, Nielsen's group released C4GEM (Dal'Molin et al., 2010b) covering maize, sorghum, and sugarcane, and Maranas' group released an improved maize model (Saha et al., 2011) derived from the work of Dal'Molin et al. (2010b) .
Pathways from the AraCyc and KEGG databases were used to create the first Arabidopsis models (Poolman et al., 2009; Dal'Molin et al., 2010a) . The refined model for AraGEM was, in turn, used as the base from which the models for maize, sorghum, and sugarcane were developed (Dal'Molin et al., 2010b; Saha et al., 2011) . The initial model in each project was subsequently expanded by using information from several databases: BRENDA (Scheer et al., 2011) and Expasy (Schneider et al., 2004) were used to complement the biochemistry, AraPerox (Reumann et al., 2004) , SUBA (Heazlewood et al., 2007) , and PPDB (Sun et al., 2009) were used to help compartmentalize reactions, and the NCBI database of plant genomes (Tatusova et al., 2007) was used by Saha et al. (2011) to find candidate genes for new reactions. Frontiers in metabolic reconstruction and modelling | 2249 plant genome-scale models that are available to date, along with the salient statistics.
Biomass compositions of current models
The current plant models differ significantly in the biomass composition used to simulate growth. The relative amounts of each biomass component are based on experimental data, but the three groups rely on entirely different sources. Poolman et al. (2009) used their own data for a heterotrophic cell culture; Dal'Molin et al. (2010a, b) used data for various tissues (Poorter and Bergkotte, 1992; Niemann et al., 1995) , supplemented with specific data on nucleic acids (Guinn, 1966) . Saha et al. (2011) used yet another four sources of data for maize or related monocots (Spector, 1956; Muller et al., 1970; de Vries et al., 1974; Wedig et al., 1987) .
The choices of data sources are related to the goals of the various studies. Poolman et al. (2009) aimed to generate a minimal model of a heterotrophic plant cell as a baseline for future work, so that data from a heterotrophic cell culture sufficed. Dal'Molin et al. (2010a, b) built self-contained leaf models, and therefore used data on leaf biomass composition. Saha et al. (2011) attempted a global model covering all plant tissues and organs and, consequently, used diverse sources of data.
The outcomes of optimizing biomass production in microbial genome-scale models have been shown to be fairly insensitive to the proportions of protein, DNA, RNA, and membrane lipid within the definition of biomass (Feist et al., 2007) . This indicates that values for these universal, energy-dense macromolecules can potentially be generalized for any cell type within a plant. However, the biomass composition for different organelles, organs, and tissues must also include the products specific to them (e.g. starch, storage lipids, and lignin). This may demand specific analyses.
Organelles in plant metabolic models
Current models also differ substantially in the representation of organelles. The first Arabidopsis model only used data on mitochondrial reactions from AraCyc, but later models included cytosolic, plastidial, mitochondrial, peroxisomal, and vacuolar compartments (Fig. 2) . Data on organellar localization came mainly from SUBA, PPDB, and AraPerox (see above). The number of reactions and compounds assigned to different organelles is still usually small, for example, <10% of all reactions in the Arabidopsis model of Saha et al. (2011) are organellar. Mintz-Oron et al. (2011) used a network-based method similar to that developed for yeast (Mintz-Oron et al., 2009) to predict many more reactions in organelles, including the endoplasmic reticulum and Golgi body; it remains to be seen whether these predictions are valid. Insofar as the vacuole has been modelled at all up to now, it has been as a simple storage facility for sucrose. This omits the many other functions of the vacuole, such as osmotic adjustment and cell expansion, nitrate storage, and detoxification.
Treatment of maintenance requirements
One critical aspect of metabolic modelling is accounting for the energetic costs of maintaining and operating the cellular machinery. Maintenance costs in metabolic models are typically divided into growth-associated maintenance (GAM) and non-growth-associated maintenance (NGAM) . NGAM is an aggregate of all energy costs associated with maintenance functions that must operate whether or not the cell is growing (e.g. maintenance of membrane potential and ion gradients, protein turnover). NGAM is captured by including a single reaction that hydrolyses ATP at a specified rate. GAM represents the energy costs associated with cell growth, which include the costs of transcription, translation, protein synthesis, and all other macromolecule assembly. GAM is captured by the inclusion of ATP hydrolysis in the biomass composition reaction with a coefficient that quantifies the amount of ATP needed to produce one gram of biomass. Together GAM and NGAM represent black boxes of cellular energy costs that have a massive influence on the yields and flux distributions predicted by the model. They are model parameters that must be adjusted to fit experimental data. In the Poolman et al. (2009) Arabidopsis heterotrophic cell model, GAM and NGAM values were adjusted to fit literature data and experimentally measured growth yields for heterotrophic cell cultures; NGAM accounted for a large proportion of total ATP consumption. All other models use a standard value of 30 mmol ATP per gram biomass for GAM, and do not set a specific value for NGAM. The value for GAM used by the current plant models represents a conservative order-of-magnitude estimate, thus the difference between the plant GAM and the E. coli GAM (Feist et al., 2007) does not necessarily represent any strong statement about the differences in the physiology of these organisms. Fitting GAM and NGAM values to experimental data for plant models other than heterotrophic cell cultures (in which substrate use can be precisely determined) is problematic, given the complexities in quantifying growth and substrate utilization rates for individual cells and tissues. One way to handle GAM and NGAM better is to represent the processes involved in more physiological detail. This has been done for GAM in bacterial models by including transcription and translation (Thiele et al., 2009) , and relevant experimental values are now available for Arabidopsis (Piques et al., 2009) . Similarly, NGAM could be handled by accounting directly for individual maintenance processes.
Identifying missing enzyme reactions and transporters
Identifying gaps in metabolic reconstructions and models
When metabolic reconstructions are converted to genomescale models, there are always gaps, many of them in pathways needed to synthesize essential metabolites. Thus, initial draft models that include only reactions and transport steps associated with annotated metabolic genes are unable accurately to simulate cell growth or its requirements . Fortunately, these draft models can be used to identify and fill the gaps in the network, thereby both improving the model and identifying deficiencies in genome annotation and in knowledge of metabolism. Models can be used to detect gaps in the metabolic network in two ways: (i) network analysis (Kumar et al., 2007) ; and (ii) flux balance analysis (FBA) (Mahadevan and Schilling, 2003) . In network analysis, known as GapFind (Kumar et al., 2007) , the pathways in all cellular compartments are examined to identify metabolites that are either consumed but not produced, or produced but not consumed. These metabolic deadends are indicative of a missing reaction or a reaction with over-constrained reversibility. While this network approach can identify many gaps, it is not always effective. Consider a pathway that culminates in a loop instead of a dead-end; such a pathway would still be incapable of functioning.
Flux balance analysis (FBA) provides an alternative means of detecting the inactive reactions that are symptomatic of network gaps. In FBA, the interior of the cell is assumed to exist at a quasi-steady-state, meaning no metabolic intermediate is allowed to be consumed or depleted (Orth et al., 2010) . This assumption results in a series of linear constraints on the flux through the reactions in the model such that the net production of each intermediate metabolite is equal to zero. This system of linear constraints is nearly always underdetermined, meaning there are many feasible flux distributions through the metabolic reactions that satisfy all constraints. FBA is used to detect inactive reactions by independently maximizing and minimizing the flux through each individual reaction and identifying inactive reactions as those with a maximum and minimum flux of zero (Mahadevan and Schilling, 2003) . The challenge in using FBA to diagnose network gaps is that it is condition-specific. Consider plants, which can grow hetero-or autotrophically. FBA may reveal no gaps that restrict growth in heterotrophic conditions, while gaps persist that prevent autotrophic growth. It is therefore important to consider all cellular operating conditions when searching for possible gaps.
Resolution of gaps in plant models
Once the gaps in a model have been identified, they must be resolved. The groups that constructed the current plant models did this in different ways. Poolman et al. (2009) simply removed all reactions that contained or led exclusively to dead-end metabolites. The other groups did not remove such reactions, leaving them as targets for future experiments and curation. Dal'Molin et al. (2010a, b) analysed the ability of the network to generate individual biomass components and, where it failed, systematically traced the network to find gaps, then filled them manually using data from AraCyc and KEGG. Saha et al. (2011) applied an optimization-based approach called GapFill (Kumar et al. 2007) automatically to suggest the minimal set of reactions that must be added or adjusted to enable the synthesis of all biomass components. In the GapFill approach, the metabolic network of the model is augmented by all the reactions included in a reference database such as AraCyc or KEGG. An FBA-based optimization is then applied to minimize the number of reactions from the reference database that must be active to enable biomass production. GapFill will nearly always produce multiple solutions to resolve model gaps. Saha et al. (2011) made directed BlastP searches to identify genes that might encode reactions suggested by GapFill. In this way, they identified the solution best supported by genomic evidence, and proposed many new annotations for the maize genome. Saha et al. (2011) also used GapFill to address gaps besides those preventing biomass synthesis, in order to provide a more complete model; this added 162 more GapFillsuggested reactions to the network. Some of these gaps corresponded to different organelle compartments or secondary metabolism, demonstrating the power of model-based gap-filling to complement knowledge of plant metabolism.
Comparative genomics approach to resolving metabolic gaps
The final step of the gap-filling process is to identify candidate genes that may specify the gap-filled reactions.
As noted above, Saha et al. (2011) used directed BlastP searches to identify gene candidates. While this approach identified many possible candidates for gap-filled reactions, it has three limitations: (i) Blast hits for such candidates are typically weak as they were most likely rejected during the original annotation process; (ii) multiple candidates are often identified with Blast scores insufficient to disambiguate whether they are isofunctional or simply homologous; and (iii) Blast searches are only as good as the reference database of sequences and annotations that is searched. None of the candidates identified by Saha et al. (2011) were experimentally tested.
A more powerful way to identify gap-filling genes is to combine comparative genomics-based prediction with experimental validation (de Crécy-Lagard and Hanson, 2007; Hanson et al., 2009) . This approach works for plants because many enzymes and some transporters are conserved between plants and prokaryotes. Moreover, functional tests of candidate genes can be efficiently made by complementing bacterial mutants with plant genes and by expressing plant proteins in bacterial hosts.
Comparative genomics exploits the 'guilt by association' principle (Aravind, 2000) , i.e. it incriminates candidate gap--filling genes via their associations with genes for related processes (e.g. flanking pathway steps). Evidence for association can come from genomic or post-genomic resources (Fig. 3) . Gene clustering-proximity in the genome-is the most globally useful type of genomic evidence (Fig. 3A) . In prokaryotes, functionally related genes are often arranged in operons or divergently transcribed from the same promoter region, or may simply be neighbours or near-neighbours (Overbeek et al., 1999; Yanai et al., 2002) . Functionally related genes can also be clustered in plants, but much less often and less tightly than in prokaryotes (Lee and Sonnhammer, 2003; Osbourn, 2010) . Gene fusions-where separate parent gene products are joined together-strongly imply functional interaction, for example, as enzymes for related reactions (Suhre, 2007) . Genes from the same pathway are often regulated in prokaryotes by a common protein recognizing a specific DNA motif (Gelfand et al., 2000) or by a common riboswitch (Winkler and Breaker, 2005) . Shared regulatory sites can thus identify sets of functionally linked genes. Lastly, there is phylogenetic cooccurrence, whose basic tenet is that genes that co-operate in a process (e.g. a metabolic pathway) will either be all present or all absent in a given organism (Osterman and Overbeek, 2003) .
Functional predictions can also be made from postgenomic evidence (Fig. 3B) . Thus, associations can be derived from co-expression datasets from microarrays (Obayashi and Kinoshita, 2010) or RNA-seq (Wang et al., 2010) . Protein-protein interaction datasets (Salwinski et al., 2004) are similarly useful, as are organellar proteome data (Sun et al., 2009) . Essentiality and other phenome data from knockout collections can associate genes with phenotypes (Tzafrir et al., 2003; Gerdes et al., 2006) . Lastly, 3D structures (Norvell and Berg, 2007) can often suggest possible enzyme activities when sequence homology cannot (Bateman et al., 2010) . Ligands with which a protein cocrystallizes (Bateman et al., 2010) , or is computationally predicted to bind (Lee et al., 2007) , can also be very helpful.
Gaps in plant networks that have been filled using comparative genomics approaches include genes for folate synthesis and transport (Klaus et al., 2005a, b) , ureide metabolism (Werner et al., 2010) , lysine synthesis (McCoy et al., 2006) , and niacin transport (Jeanguenin et al., 2011) .
Modelling tissue-specific processes
Genome-scale metabolic modelling of plants or other higher organisms clearly involves the complexity of specific cell types with distinct capacities. While the modularity of tissues and organs means they can sometimes be treated as independent, homogeneous units, in many cases this not so. For example, the C 4 leaf requires interaction between two cell types (mesophyll and bundle sheath). Any effort to model a whole plant, particularly through developmental stages and various temporal cycles (e.g. day/night and seasonal cycles), would require simultaneous modelling of many different cell types in several connected tissues/organs. Development of such models remains out of reach, but genome-scale metabolic models are currently being applied to elucidate functional differences between cell types in various tissues and to simulate how different cell types interact (Lewis et al., 2010; Dal'Molin et al., 2010b) .
The first challenge in modelling tissue-specific metabolism is to define which enzymatic and transport reactions are active in a given tissue. This requires evidence that the reaction, or the protein mediating it, occurs there. The most direct evidence comes from in vivo isotope tracer studies (e.g. Hanson and Rhodes, 1983; Rathinasabapathi et al., 1993) but such data tend to be scarce. Transcriptome analyses (e.g. Cheung et al., 2006; Hansen et al. 2009; Wang et al., 2010) and proteome analyses (e.g. Jorrin-Novo et al. 2009; Sun et al., 2009) are more often available, but do not provide definitive evidence; the presence of an mRNA does not prove that its protein is present, and the absence of a protein from a proteomics dataset does not prove its absence from the sample. Finally, metabolome analyses (e.g. Fernie, 2007; Moco et al., 2009) can establish the presence of a compound. While not proof of the presence of related enzymes, metabolomics data can constitute strong indirect evidence, particularly if coupled with proteome or transcriptome data or with protein targeting predictions.
The first tissue-specific genome-scale models were built from a generic model of human metabolism (Homo sapiens Recon 1; Duarte et al., 2007) . Shlomi et al. (2008) used available transcriptomic and proteomic data to constrain this global model into ten different models, each representing a human tissue. Mintz-Oron et al. (2011) applied a similar technique (Jerby et al., 2010) to Arabidopsis to produce ten models for specific tissue types and developmental stages. These models can be studied independently, but not in interaction with each other.
By contrast, Lewis et al. (2010) and Dal'Molin et al. (2010b) incorporated multiple tissues (in the human brain and the maize leaf, respectively) in a single model. The brain model (Lewis et al., 2010) has two cell types (neuron and astrocyte), each with a mitochondrial compartment, joined by two interfaces, the interstitium and the endothelium (where blood flow occurs). The latter two are modelled as separate compartments, with transport reactions exchanging metabolites between them. Dal'Molin et al. (2010b) likewise modelled two leaf cell types, mesophyll and bundlesheath, along with a separate compartment representing plasmodesmata. These pioneering efforts point to what will be needed to achieve a complete genome-scale plant model: modelling of multiple tissues, coupling these tissue models via cell/tissue interfaces, and doing so dynamically, at each level of plant organization.
Confronting undiscovered genome content
The scale of the problem Some 30-40% of the proteins encoded by typical bacterial genomes have no clearly known function, and such functionally undiscovered genome content makes up an even higher percentage of plant genomes (Frishman, 2007; Hanson et al., 2009) . Many of the unknown proteins in this undiscovered content belong to widely conserved families (Galperin and Koonin, 2010) and ;40% of them are most probably enzymes or transporters (Freilich et al., 2005; Molina and van Nimwegen, 2009) . Thus, most genomes contain hundreds to thousands of conserved enzymes and transporters of unknown function. Unfortunately, databases often over-annotate such proteins based on homology, that is, assign them an overly specific function (Schnoes et al., 2009 )-which of course degrades metabolic reconstructions and corrupts models.
Metabolite repair proteins
Part of functionally undiscovered genome content must be the missing enzymes and transporters that give rise to network gaps. Recent bioinformatic and experimental evidence indicates that another significant tranche consists of proteins that deal with damage done to metabolites by spontaneous chemical reactions and enzymatic mistakes (Van Schaftingen et al., 2009; Galperin and Koonin, 2010; Vinci and Clarke, 2010) . These damagecountering activities, which are analogous to the processes of DNA and protein repair, have been collectively termed metabolite repair (Van Schaftingen et al., 2009) . This is a convenient shorthand term; alternatives include metabolite damage-control and metabolic clean-up.
Examples of metabolite damage and repair
Over 20 types of metabolite damage and repair reactions have now been documented (Fukui et al., 1965; Izumi et al., 1973; Pierson and Campbell, 1990; Stover and Schirch, 1993; di Salvo et al., 2003; Cooper, 2004; Zimny et al., 2006; Van Schaftingen et al., 2009; Vinci and Clarke, 2010; Jeanguenin et al., 2010; Lee and Gladyshev, 2011) . Many more must exist (Golubev, 1996; Galperin and Koonin, 2010) . The two following cases, from animals and microbes, are clear-cut examples. The metabolite damage is caused by imperfect enzyme specificity in the first case, and by a spontaneous chemical reaction in the second. Case 1. 2-Oxoglutarate (2-OG) is a central intermediate of carbon and nitrogen metabolism. A side-reaction of mammalian and bacterial L-malate dehydrogenase can reduce it to L-2-hydroxyglutarate (Fig. 4A) , which has no physiological function and is toxic (Wright and Viola, 2001; Van Schaftingen et al., 2009) . In mammals and, probably, Escherichia coli, the repair enzyme L-2-hydroxyglutarate dehydrogenase oxidizes L-2-hydroxyglutarate back to 2-OG in an FAD-dependent reaction (Kalliri et al., 2008; Van Schaftingen et al., 2009) (Fig. 4A) . The mammalian and bacterial L-2-hydroxyglutarate dehydrogenases are homologous. 2-OG is vulnerable to a second sort of damage that mirrors the first. Side-reactions of bacterial D-3-phosphoglycerate dehydrogenase and variant forms of mammalian isocitrate dehydrogenase (Zhao and Winkler, 1996; Dang et al., 2009; Kranendijk et al., 2010) reduce it to D-2-hydroxyglutarate (Fig. 4A) . Like the L-form, the D-form is toxic (Latini et al., 2003; Dang et al., 2009) . The D-form is re-oxidized to 2-OG by D-2-hydroxyglutarate dehydrogenase (Achouri et al., 2004) . These twin examples illustrate two principles. (i) Metabolite repair is often needed because enzymes are not absolutely specific. Imperfect specificity, also called catalytic promiscuity (Khersonsky and Tawfik, 2010) or 'messiness' (Tawfik, 2010) , is an inherent characteristic of all enzymes, not just those conventionally held to have a broad substrate range. (ii) Repair enzymes as well as those that cause damage can be widely conserved.
Case 2. In physiological conditions, the natural (S,S) form of S-adenosylmethionine (AdoMet) racemizes spontaneously to the inactive (R,S) form (Hoffman, 1986) (Fig. 4B) . (R,S)-AdoMet levels in vivo, however, remain relatively low (Hoffman, 1986) . How cells dispose of (R,S)-AdoMet was a mystery until two homocysteine methyltransferases in yeast (Mht1p and Sam4p) were found to use (R,S)-AdoMet Clarke, 2007, 2010) . This work also found (R,S)-AdoMet-dependent homocysteine methyltransferase activity in Arabidopsis (Vinci and Clarke, 2007) . This example illustrates how the need for metabolite repair can stem from chemical damage, and underscores the wide distribution of repair enzymes. It also shows how repair can entail more than a simple reversal of the original damage reaction. In this case, the damaged metabolite is dismantled and rebuilt: homocysteine methyltransferase action converts (R,S)-AdoMet to S-adenosylhomocysteine, from which (S,S)-AdoMet is regenerated via the normal methyl cycle (Fig. 4B ).
Comparative genomics of metabolite repair genes
Comparative genomics principles (Fig. 3) predict that metabolite repair genes will be associated with genes that make, use, or transport damage-prone metabolites. The above cases fit this prediction. Thus, bacterial L-2-hydroxyglutarate dehydrogenase genes (ygaF) are commonly clustered with genes encoding 2-OG-metabolizing enzymes including 2-OG dehydrogenase and succinyl-CoA ligase in e.g. Marinomonas, and c-aminobutyrate transaminase (gabT) and other c-aminobutyrate utilization (gab) genes in E. coli and other c-proteobacteria (Fig. 4C) . Similarly, D-2-hydroxyglutarate dehydrogenase (DHGDH) genes occur next to genes for D-3-phosphoglycerate dehydrogenase (serA), i.e. the damage enzyme, in diverse proteobacteria (e.g. Myxococcus, Xanthomonas) (Fig. 4C) . The yeast homocysteine methyltransferase gene SAM4 is next to an AdoMet transporter gene (SAM3). Also, in diverse bacteria (e.g. E .coli, Bacillus, and Lactobacillus species), genes (mmuM) encoding homologues of the yeast methyltransferases flank genes (mmuP) predicted to encode basic amino acid transporters (Fig. 4C) ; AdoMet is a basic amino acid. There is evidence that E. coli MmuP transports the AdoMet analoue S-methylmethionine (Thanbichler et al., 1999) ; AdoMet seems not to have been tested. Collectively, these retrospective observations indicate that comparative genomics can help to find new repair enzymes.
Modelling implications of metabolite damage and repair
If metabolite damage and repair processes are indeed as active and universal as they are starting to seem, there are significant implications for reconstructing and modelling metabolism. This can be readily appreciated by considering the Rubisco oxygenase (damage) reaction and the photorespiratory (repair) pathway that releases about 25% of the CO 2 fixed in photosynthesis (Oliver, 1994) . However, except for Rubisco and photorespiration, current models take no account of the costs of metabolite damage and repair, which could contribute substantially to maintenance costs (these being, at present, a large black box, as noted above). The racemization and repair of AdoMet, for instance, involve the following sequence of reactions ( The costly sum of these reactions is the complete hydrolysis of one ATP to adenosine, pyrophosphate, and phosphate. This example makes plain why identifying and quantifying metabolite damage and repair processes constitute an important frontier in metabolism, in general, and genome-scale metabolic models in particular.
